Wegovy 7.2mg Price UK: What to Expect From Private Treatment Costs

The regulatory moment that changed the 7.2mg picture

For much of 2025, reaching 7.2mg weekly meant taking three separate 2.4mg pens in a single week — logistically complicated and relatively expensive. The MHRA changed that on 14 April 2026, approving a purpose-built single-dose 7.2mg pen: one injection, one dose, one pen per week. That approval, announced on GOV.UK, is specific to adults with a BMI of 30 or above (not for the cardiovascular indication) with the 0.25mg starting dose and the same four-weekly titration schedule applying throughout.

The clinical trial data behind 7.2mg is striking. Trials reported roughly 20.7% average weight loss over 72 weeks at this dose, which narrows the gap considerably with tirzepatide 15mg results. That evidence base is partly why demand has grown quickly since approval. Supply and prescriber confidence at this dose are still maturing across the private sector, which is one reason Wegovy 7.2mg costs reported across providers vary more than at lower doses. The sensible move is to confirm what any quoted price covers before you read too much into the number itself.

If you're new to semaglutide, the full Wegovy overview gives the starting-point context on how the treatment programme works from week one.

Why headline Wegovy prices often leave things out

A quoted monthly figure for Wegovy 7.2mg in the UK can mean quite different things depending on the provider. Some prices cover the medicine alone, the consultation that produced your prescription sits separately, sometimes as a one-off charge, sometimes as a recurring fee billed alongside each repeat. Delivery may be extra. Aftercare (the clinical support you need if nausea hits badly or you want advice on a missed dose) is sometimes bundled, sometimes charged per contact, sometimes absent entirely.

The result is that comparing two headline figures side by side rarely tells you what you'll actually spend over a treatment course. A lower monthly number with a £49 consultation fee and £6.99 delivery on each repeat can easily exceed a higher headline that covers everything. This isn't a small print problem unique to weight-loss medicines; it's a pattern common to any subscription-adjacent health service. The useful question is: what does this price include when I need clinical support at 3pm on a Saturday?

For background on how Wegovy pricing works at earlier doses, the Wegovy price overview covers the full dose range in the same honest terms.

What sets the price at this dose, and how nume positions itself

At the 7.2mg stage, a patient is typically several months into treatment. Repeat orders at this dose require a clinical review, checking weight progress, tolerability, and whether 7.2mg remains the right maintenance level. That review should happen before every repeat, not as a courtesy but as a regulatory expectation for a prescription medicine. If a provider's pricing model doesn't factor in that ongoing clinical work, ask where it goes.

We're not the cheapest option, and that's deliberate. At nume, one price covers the consultation, the prescription, the medicine, and free next-working-day tracked delivery by DPD, the pen arrives in plain packaging, no indication of contents. There are no subscription charges and no auto-renewals; every repeat is a fresh clinical assessment by a GPhC-registered Independent Prescriber. You can see the current treatment pricing on the treatment page, and our clinical team information is there if you want to know who's actually reviewing your case.

One practical note: at 7.2mg, storage is the same as at any other Wegovy dose, the pen lives in the fridge, typically 2 to 8°C, though the exact room-temperature window if you're travelling is in the Patient Information Leaflet rather than something to guess at. Many patients keep it in the fridge door as part of a weekly routine, visible, accessible, easy to remember.

Why price is the wrong starting point for a prescription medicine

The MHRA has issued repeated warnings about semaglutide pens being sold online, sometimes counterfeit, sometimes without a prescription being issued at all. In 2025, enforcement operations seized approximately 20 million doses of illegally traded weight-loss medicines worth around £45 million, and the first UK site manufacturing fake tirzepatide pens was raided. You can report suspect sellers through the Yellow Card scheme, and any legitimate pharmacy can be verified against the GPhC register.

For a medicine that requires titration over months, where a prescriber's ongoing involvement genuinely affects both safety and results, the cost comparison that matters is not which provider quotes the lowest figure. It is which provider offers a genuine licensed supply chain, proper clinical review at each stage, and accessible support when side effects or questions arise. A modest saving per pen is not a meaningful trade-off against those factors.

If you're considering treatment at any dose (not just 7.2mg) a free consultation is the right place to start. Our prescribers review eligibility, current health, and what a realistic treatment plan looks like before anything is prescribed, including understanding how Wegovy 1mg is priced in the UK compared with later maintenance doses, or how Wegovy 0.5mg is priced for those at the early titration stage. You can also browse the broader weight-loss treatment options if you're still comparing approaches, or read common questions before booking.